Exploring how small RNAs from bacteria can influence host health
Small RNAs as Novel Modulators of Microbe-Host Interactions
This study is looking at how tiny molecules made by bacteria can affect the way our bodies respond to infections, with the goal of creating new treatments that work better against antibiotic-resistant bacteria, so patients can have more effective options for healing.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Princeton University NIH-funded |
| Lab location | 1 site (Princeton, UNITED STATES) |
| Project ID | NIH-11082393 on NIH RePORTER |
What this research studies
This research investigates the role of small RNAs (sRNAs) produced by bacteria in modulating interactions with their host organisms. By understanding how these sRNAs can be sensed and responded to by animals, the research aims to develop new therapeutic strategies to combat antibiotic-resistant bacterial infections. The approach leverages recent discoveries in nucleic acid-based therapies, which have shown promise in rapidly developing effective treatments. Patients may benefit from innovative RNA-based interventions that target bacterial pathogens more effectively than traditional antibiotics.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from infections caused by antibiotic-resistant bacteria or those with conditions influenced by their microbiome.
Not a fit: Patients with infections that are not caused by bacterial pathogens or those who do not have antibiotic resistance issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for infections caused by antibiotic-resistant bacteria.
How similar studies have performed: Other research has shown success with RNA-based therapies in treating specific conditions, indicating potential for this novel approach.
Where this research is happening
Princeton, UNITED STATES
- Princeton University — Princeton, United States (Active)
Researchers
- Principal investigator: Gitai, Zemer — Princeton University
- Study coordinator: Gitai, Zemer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.